Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China
· Delayed Price · Currency is CNY 36.26
-0.01 (-0.03%)
Apr 29, 2026, 3:00 PM CST
SHA:603590 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 5,766 | 6,321 | 3,724 | 5,959 | 3,903 | 5,084 | Upgrade
|
| Market Cap Growth | 36.89% | 69.72% | -37.51% | 52.69% | -23.24% | -12.98% | Upgrade
|
| Enterprise Value | 5,596 | 5,970 | 3,614 | 5,764 | 3,593 | 4,468 | Upgrade
|
| Last Close Price | 36.26 | 39.75 | 23.07 | 36.90 | 24.02 | 30.95 | Upgrade
|
| PE Ratio | 34.22 | 38.08 | 88.21 | 39.61 | 38.46 | 34.36 | Upgrade
|
| PS Ratio | 6.28 | 6.91 | 4.51 | 6.48 | 4.50 | 6.28 | Upgrade
|
| PB Ratio | 1.64 | 1.81 | 1.09 | 1.77 | 1.22 | 1.62 | Upgrade
|
| P/TBV Ratio | 2.41 | 2.66 | 1.62 | 2.83 | 1.94 | 2.57 | Upgrade
|
| P/FCF Ratio | 45.08 | 101.57 | 54.59 | 60.54 | 166.94 | - | Upgrade
|
| P/OCF Ratio | 34.36 | 54.64 | 21.62 | 29.89 | 32.61 | 90.44 | Upgrade
|
| EV/Sales Ratio | 6.10 | 6.52 | 4.38 | 6.27 | 4.15 | 5.52 | Upgrade
|
| EV/EBITDA Ratio | 23.62 | 25.74 | 24.63 | 34.86 | 23.71 | 30.97 | Upgrade
|
| EV/EBIT Ratio | 27.95 | 30.06 | 30.43 | 44.49 | 30.07 | 39.71 | Upgrade
|
| EV/FCF Ratio | 43.75 | 95.94 | 52.97 | 58.55 | 153.69 | - | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.09 | 0.06 | 0.05 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 1.40 | 1.37 | 1.38 | 0.87 | 0.08 | 0.13 | Upgrade
|
| Debt / FCF Ratio | 2.59 | 5.15 | 3.07 | 1.52 | 0.53 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.13 | -0.15 | -0.14 | -0.20 | -0.19 | -0.19 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.94 | -2.21 | -3.30 | -4.00 | -4.05 | -4.16 | Upgrade
|
| Net Debt / FCF Ratio | -3.57 | -8.24 | -7.11 | -6.71 | -26.26 | 5.54 | Upgrade
|
| Asset Turnover | 0.23 | 0.23 | 0.21 | 0.26 | 0.26 | 0.23 | Upgrade
|
| Inventory Turnover | 1.45 | 1.45 | 1.43 | 2.37 | 3.02 | 2.61 | Upgrade
|
| Quick Ratio | 2.63 | 2.58 | 2.80 | 3.49 | 5.51 | 5.62 | Upgrade
|
| Current Ratio | 3.05 | 3.04 | 3.08 | 3.80 | 5.90 | 6.12 | Upgrade
|
| Return on Equity (ROE) | 4.89% | 4.90% | 0.63% | 5.73% | 3.92% | 5.39% | Upgrade
|
| Return on Assets (ROA) | 3.14% | 3.10% | 1.93% | 2.25% | 2.20% | 1.97% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.84% | 5.99% | 2.33% | 4.91% | 4.13% | 4.85% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.50% | 5.50% | 3.30% | 3.70% | 3.70% | 3.50% | Upgrade
|
| Earnings Yield | 2.93% | 2.63% | 1.13% | 2.53% | 2.60% | 2.91% | Upgrade
|
| FCF Yield | 2.22% | 0.98% | 1.83% | 1.65% | 0.60% | -2.13% | Upgrade
|
| Dividend Yield | 1.65% | - | 2.60% | 0.81% | 0.83% | 0.97% | Upgrade
|
| Payout Ratio | 61.09% | 61.70% | 126.71% | 23.23% | 46.26% | 37.58% | Upgrade
|
| Buyback Yield / Dilution | -1.07% | -2.06% | 0.23% | -0.37% | 0.82% | 1.26% | Upgrade
|
| Total Shareholder Return | 0.59% | -2.06% | 2.83% | 0.44% | 1.65% | 2.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.